BioStock | Sprint Bioscience | November 2022

01 November 2022 - 09:30
BioStock intervjuar Erik Kinnman, vd på Sprint Bioscience, om bolagets portfölj, framtidsplaner och den pågående emissionen....
Nasdaq First North GM Stockholm (Sweden)
Sprint Bioscience AB
Sprint Bioscience is a Sweden based company involved in developing drugs focused on cancer and metabolism. The project portfolio of the company includes STK25, VPS34, and PIP4K2....
Learn more about company

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More